Yashoda Hospitals
Malakpet
Dr. Kalyan's Speciality Clinic
Hasthinapuram
Call Us
+91-7207897798
+91-9392172078
Malakpet
Hasthinapuram
+91-7207897798
+91-9392172078
Stereotactic Body Radiotherapy (SBRT), also known as Stereotactic Ablative Radiotherapy (SABR), is an advanced form of radiation therapy that delivers highly precise, high-dose radiation to tumors while minimizing exposure to surrounding healthy tissues. This cutting-edge treatment technique is commonly used for tumors in the lung, liver, spine, and bones, particularly when surgery is not feasible or when a minimally invasive treatment option is preferred. SBRT/SABR combines sophisticated imaging, motion management, and computer-guided radiation delivery to accurately target cancer cells over a small number of treatment sessions. The precision of this approach allows effective tumor control while helping patients maintain their quality of life throughout treatment.
SBRT/SABR is not used to treat a specific cause but rather to manage tumors that arise from various underlying conditions. Lung tumors may develop due to smoking, environmental exposures, genetic factors, or previous lung disease. Liver tumors can occur as a result of chronic liver disease, viral hepatitis, cirrhosis, or metastatic spread from cancers originating elsewhere in the body. Bone tumors may be primary cancers of the bone or, more commonly, cancer that has spread from organs such as the breast, lung, prostate, or kidney. When these tumors are localized and suitable for targeted radiation treatment, SBRT/SABR can provide an effective therapeutic option.
The symptoms associated with tumors treated by SBRT/SABR vary depending on their location and size. Lung tumors may cause persistent cough, shortness of breath, chest discomfort, wheezing, or coughing up blood. Liver tumors can present with abdominal pain, fullness, fatigue, loss of appetite, unexplained weight loss, or jaundice. Bone tumors or metastatic lesions often cause localized pain, tenderness, swelling, restricted movement, or an increased risk of fractures. In some cases, tumors may be detected incidentally during imaging studies performed for unrelated reasons before symptoms become apparent.
A thorough evaluation is essential before recommending SBRT/SABR. The diagnostic process typically includes a detailed medical history, physical examination, and advanced imaging studies such as CT scans, MRI scans, or PET-CT scans to determine the size, location, and extent of the tumor. In many cases, a biopsy may be performed to confirm the diagnosis and identify the specific type of cancer. During treatment planning, specialized imaging and simulation procedures are used to precisely map the tumor and account for movement caused by breathing or normal body functions. This meticulous planning ensures that radiation is delivered with maximum accuracy and effectiveness.
SBRT/SABR is often recommended for patients with small, well-defined tumors or limited metastatic disease where precise radiation delivery can achieve excellent local control. Treatment is usually completed in a few sessions, making it more convenient than conventional radiation therapy that may require several weeks of treatment. Depending on the patient’s condition, SBRT/SABR may be used as a primary treatment, an alternative to surgery, or in combination with other cancer therapies such as chemotherapy, immunotherapy, targeted therapy, or hormonal therapy. For bone metastases, SBRT can provide significant pain relief and improve structural stability, while for lung and liver tumors it can offer effective tumor control with minimal disruption to daily life.
Following SBRT/SABR, regular follow-up appointments are important to monitor treatment response and overall health. Imaging studies are typically performed at scheduled intervals to assess tumor shrinkage and ensure that there are no signs of recurrence or progression. Most patients are able to resume normal activities shortly after treatment, although some may experience temporary fatigue or mild treatment-related symptoms. Maintaining good nutrition, staying physically active within comfort limits, and following the healthcare team’s recommendations can support recovery and long-term well-being. Continuous monitoring allows any concerns to be addressed promptly and helps optimize treatment outcomes.
SBRT/SABR is generally well tolerated and is designed to reduce the risk of damage to healthy tissues. However, as with any cancer treatment, certain side effects and complications may occur. The nature of these effects depends on the treatment area and individual patient factors. Patients receiving lung SBRT may experience fatigue, cough, shortness of breath, or inflammation of lung tissue. Liver SBRT can occasionally cause temporary liver irritation or changes in liver function. Treatment for bone lesions may lead to temporary discomfort, swelling, or inflammation near the treated area. Serious complications are uncommon due to the high level of precision used in treatment planning and delivery, but close follow-up remains essential to ensure patient safety.
Patients should seek medical attention if they experience persistent symptoms such as unexplained cough, breathing difficulties, chest pain, abdominal discomfort, bone pain, unexplained weight loss, fatigue, or any new symptoms that do not improve over time. Individuals with a known cancer diagnosis should consult a radiation oncologist to determine whether SBRT/SABR may be an appropriate treatment option. Early evaluation and timely intervention can significantly improve treatment outcomes and provide access to advanced therapies that are tailored to each patient’s specific condition. A personalized consultation helps ensure that every patient receives the most suitable and effective cancer care plan.